The intricate pathways of drug discovery often hinge on the availability and precise application of specialized chemical intermediates. CAS 135865-78-0, known chemically as (S)-Tert-Butyl 3-Oxo-1-Phenylpropylcarbamate, stands out as a critical component in the synthesis of CCR5 chemokine receptor modulators. These modulators are at the forefront of therapeutic strategies for conditions like HIV, where CCR5 receptors on immune cells are crucial for viral entry. By developing compounds that can block or modulate these receptors, scientists aim to disrupt viral replication and progression.

The chemical structure of (S)-Tert-Butyl 3-Oxo-1-Phenylpropylcarbamate lends itself to the precise construction of spirotropane frameworks, which are characteristic of many potent CCR5 antagonists. The ability to reliably purchase this intermediate allows pharmaceutical companies to streamline their synthesis processes, moving efficiently from laboratory-scale experiments to larger production batches. The consistent quality associated with this Maraviroc intermediate ensures that researchers can depend on its performance in multi-step synthetic routes, ultimately accelerating the development timelines for new medications.

Beyond its role in HIV therapeutics, the modulation of CCR5 receptors is also being explored for its potential in treating other diseases, including certain cancers and inflammatory disorders. This broadens the significance of intermediates like (S)-Tert-Butyl 3-Oxo-1-Phenylpropylcarbamate even further. As the demand for innovative therapies grows, so does the need for accessible and high-purity chemical building blocks. Understanding the specific uses and chemical properties of compounds like CAS 135865-78-0 is essential for any organization involved in advanced pharmaceutical research and manufacturing.